Serious adverse events during a 6-min walk test in patients with pulmonary hypertension

European Respiratory Journal

Volumn 45, Issue 4, 2015, Pages 1179-1182

  Morris, Norman R ^a,b   Seale, Helen ^b   Harris, Julie ^b   Hall, Kathleen ^b   Hopkins, Peter ^b   Kermeen, Fiona ^b  

^a GRIFFITH UNIVERSITY   (Australia)

^b THE PRINCE CHARLES HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ATROPINE;

ADULT; ADVERSE OUTCOME; AGED; ARTERIAL OXYGEN SATURATION; ARTIFICIAL VENTILATION; CARDIOPULMONARY EXERCISE TEST; CASE REPORT; CAUSE OF DEATH; COLLAPSE; DEFIBRILLATION; DIZZINESS; ECHOCARDIOGRAPHY; FAINTNESS; FEMALE; HEART ARREST; HEART LEFT VENTRICLE FAILURE; HEART RIGHT VENTRICLE FAILURE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; INTUBATION; LETTER; MALE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RESUSCITATION; SAFETY; SIX MINUTE WALK TEST; THORAX PAIN; TRANSCUTANEOUS PACEMAKER; WALKING SPEED; ADVERSE EFFECTS; CRITICAL ILLNESS; ELECTROCARDIOGRAPHY; EPIDEMIOLOGY; EXERCISE TEST; HYPERTENSION, PULMONARY; PROCEDURES; RISK ASSESSMENT; SYNCOPE; TIME; TREATMENT OUTCOME; VENTRICULAR FIBRILLATION;

ADULT; AGED; CARDIOPULMONARY RESUSCITATION; CRITICAL ILLNESS; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MALE; RISK ASSESSMENT; SAMPLING STUDIES; SYNCOPE; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FIBRILLATION;

EID: 84926512699     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00146914     Document Type: Letter

References (11)

1. American Thoracic Society. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166: 111-117.
2. Galiè N, Corris PA, Frost A, et al. Updated treatment algorithm of pulmonary arterial hypertension. J Am Coll Cardiol 2013; 62: Suppl. 25, D60-D72.
3. USFDA. Code of Federal Regulations Title 21, Volume 5. Food and Drug Administration Department of Health and Human Services Subchapter D - Drugs for Human Use. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/cfrsearch.cfm?fr=312.32 Date last updated: April 1, 2014. Date last accessed: July 3, 2014.
4. Enright PL, McBurnie MA, Bittner V, et al. The 6-min walk test: a quick measure of functional status in elderly adults. Chest 2003; 123: 387-398.
5. Jenkins S, Cecins N. Six-minute walk test: observed adverse events and oxygen desaturation in a large cohort of patients with chronic lung disease. Intern Med J 2011; 41: 416-422.
6. Simonneau G, Gatzoulis MA, Adatia I, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2013; 62: Suppl. 25, D34-D41.
7. Ameri A. Six minute walk test in respiratory diseases: a university hospital experience. Ann Thorac Med 2006; 1: 16-19.
8. Hoeper MM, Bogaard HJ, Condliffe R, et al. Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol 2013; 62: Suppl. 25, D42-D50.
9. Hoeper MM, Galié N, Murali S, et al. Outcome after cardiopulmonary resuscitation in patients with pulmonary arterial hypertension. Am J Respir Crit Care Med 2002; 165: 341-344.
10. Rajdev A, Garan H, Biviano A. Arrhythmias in pulmonary arterial hypertension. Prog Cardiovasc Dis 2012; 55: 180-186.
11. Park JH, Jegal Y, Shim TS, et al. Hypoxemia and arrhythmia during daily activities and six-minute walk test in fibrotic interstitial lung diseases. J Korean Med Sci 2011; 26: 372-378.